Consensus Bio-Rad Laboratories, Inc. Nyse

Equities

BIO.B

US0905721082

Market Closed - Nyse Other stock markets 21:15:00 10/05/2024 BST			5-day change	1st Jan Change
279.9 ^USD	0.00%		-14.31%	-12.71%

05-08	UBS Adjusts Price Target on Bio-Rad Laboratories to $385 From $420, Maintains Buy Rating	MT
05-08	RBC Adjusts Price Target on Bio-Rad Laboratories to $414 From $420	MT

Evolution of the average Target Price on Bio-Rad Laboratories, Inc.

Price target over the last 5 years

History of analyst recommendation changes

b8a40ac5a0a4160a1341959dce12dbc4._way4OjE2ayMxBIvl6f0WFZGgwAZfyJsEIxV6rlKsBY.qEXEmpGnld_msWJgoNeFECwn8mZYPBANUdgBs-s-8We3aIqojZOhzer9cQ~e1362f97c77e75a4348144c74c77042d

Analyst Recommendations on Bio-Rad Laboratories, Inc.

UBS Adjusts Price Target on Bio-Rad Laboratories to $385 From $420, Maintains Buy Rating	05-08	MT
RBC Adjusts Price Target on Bio-Rad Laboratories to $414 From $420	05-08	MT
Citigroup Adjusts Price Target on Bio-Rad Laboratories to $300 From $365	05-08	MT
RBC Capital Adjusts Price Target on Bio-Rad Laboratories to $420 From $474	04-29	MT
Zacks Investment Research Lowers Price Target on Bio-Rad Laboratories to $285 From $322	04-15	MT
RBC Trims Price Target on Bio-Rad Laboratories to $474 From $480, Keeps Outperform Rating	04-08	MT
Citigroup Downgrades Bio-Rad Laboratories to Neutral From Buy, Adjusts Price Target to $365 From $400	04-03	MT
UBS Adjusts Bio-Rad Laboratories Price Target to $420 From $395, Maintains Buy Rating	02-16	MT
RBC Trims Price Target on Bio-Rad Laboratories to $480 From $484, Keeps Outperform Rating	02-16	MT
Analyst recommendations: Blackstone, Citigroup, Icon, Amazon, Broadcom...	01-03
UBS Initiates Coverage on Bio-Rad Laboratories With Buy Rating, $395 Price Target	12-07	MT
RBC Cuts Price Target on Bio-Rad Laboratories to $482 From $513, Notes 'Near-Term Headwinds,' Keeps Outperform Rating	27/10/23	MT
ANALYST RECOMMENDATIONS : Amazon, Comcast, Intel, Merck, Roblox...	27/10/23
Wells Fargo Adjusts Price Target on Bio-Rad Laboratories to $525 From $550, Keeps Overweight Rating	07/08/23	MT
Wells Fargo Lowers Price Target on Bio-Rad Laboratories to $525 From $550, Maintains Overweight Rating	07/08/23	MT
Credit Suisse Adjusts Bio-Rad Laboratories' Price Target to $550 From $580, Keeps Outperform Rating	04/08/23	MT
RBC Raises Price Target on Bio-Rad Laboratories to $524 From $522, Maintains Outperform Rating	04/08/23	MT
RBC Cuts Bio-Rad Laboratories' Price Target to $522 From $536, Keeps Outperform Rating	17/07/23	MT
Wells Fargo Initiates Bio-Rad Laboratories With Overweight Rating, $550 Price Target	16/06/23	MT
ANALYST RECOMMENDATIONS : Adobe, Wells Fargo, American Express...	16/06/23
RBC Boosts Price Target on Bio-Rad Laboratories to $536 From $531, Maintains Outperform Rating	15/05/23	MT
Citigroup Adjusts Bio-Rad Laboratories' Price Target to $525 From $550, Keeps Buy Rating	08/05/23	MT
RBC Cuts Price Target on Bio-Rad Laboratories to $531 From $582 After Guidance Cut But Sees Buying Opportunity After Stock Drop; Outperform Kept	08/05/23	MT
Credit Suisse Cuts Bio-Rad Laboratories' PT to $580 From $680 After Lower-Than-Expected Q1 Results, Keeps Outperform Rating	05/05/23	MT
RBC Boosts Price Target on Bio-Rad Laboratories to $582 From $579, Maintains Outperform Rating	14/04/23	MT